Tag: Progression-free survival

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Progression-free survival

Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer

Added to Collection on: 2023-10-21 21:32:19

Tags for this article:

Orphan drugs
Breakthrough therapy
Monoclonal antibodies
Antineoplastic drugs
Durvalumab
Lactams
Olaparib
PARP inhibitor
Progression-free survival
Carboplatin
Paclitaxel

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi combination shows promise in phase 3 liver cancer study - PMLiVE

Added to Collection on: 2024-01-23 13:43:45

Tags for this article:

Orphan drugs
Hepatology
Monoclonal antibodies
Infectious causes of cancer
Durvalumab
Hepatocellular carcinoma
Progression-free survival
Liver cancer
Tremelimumab
Bevacizumab
Clinical endpoint
Bland embolization
Avastin
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
U.S. FDA approves AstraZeneca's Tagrisso-chemo combo - Yahoo Finance

Added to Collection on: 2024-02-17 10:14:33

Tags for this article:

Antineoplastic drugs
Orphan drugs
Medical terminology
Progression-free survival
AstraZeneca
Food and Drug Administration
Ramucirumab
Gefitinib
Tagrisso
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic ...

Added to Collection on: 2024-04-28 16:21:06

Tags for this article:

Hepatology
Clinical endpoint
Progression-free survival
Hepatocellular carcinoma
Bland embolization

Click the tags to see associated articles and topics

View Article Details
Covalent BTK Inhibitors: A Review of the Evidence in Chronic Lymphocytic Leukemia

Added to Collection on: 2024-06-14 13:07:54

Tags for this article:

Orphan drugs
Tyrosine kinase inhibitors
Piperidines
Antineoplastic drugs
Chronic lymphocytic leukemia
Acalabrutinib
Ibrutinib
Bruton's tyrosine kinase
Zanubrutinib
Obinutuzumab
Progression-free survival

Click the tags to see associated articles and topics

View Article Details
BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing ...

Added to Collection on: 2024-06-22 11:23:43

Tags for this article:

Orphan drugs
Multiple myeloma
Bortezomib
Isatuximab
Lenalidomide
Peripheral neuropathy
Minimal residual disease
Progression-free survival
Dexamethasone
AUSTIN
James A. Davis

Click the tags to see associated articles and topics

View Article Details
AstraZeneca says ENHERTU achieved 61.6% progression-free survival rate in study

Added to Collection on: 2024-09-13 14:11:35

Tags for this article:

Antineoplastic drugs
AstraZeneca
Medical research
Södertälje Municipality
Brain metastasis
Antibody-drug conjugate
Progression-free survival
Trastuzumab deruxtecan
Metastatic breast cancer
Daiichi Sankyo
Oxford–AstraZeneca COVID-19 vaccine

Click the tags to see associated articles and topics

View Article Details
Long-Term KEYNOTE-006 Data Support Pembrolizumab as SOC in Advanced Melanoma

Added to Collection on: 2024-09-15 17:12:08

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Ipilimumab
Melanoma
Merck & Co.
Progression-free survival
Uveal melanoma
MRNA-4157/V940
TIGIT
Caroline Robert

Click the tags to see associated articles and topics

View Article Details
Allogeneic T-Cell Therapy Produces Efficacy at 10 Months in Stage IV Metastatic NSCLC

Added to Collection on: 2024-10-01 21:32:17

Tags for this article:

Lung cancer
Medical terminology
Progression-free survival
Radiation therapy
Non-small-cell lung cancer
Kiromic BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
The Impact of Immune-Related Adverse Events on the Outcome of Advanced Gastric Cancer ...

Added to Collection on: 2024-12-09 19:25:45

Tags for this article:

Medical terminology
Progression-free survival
Shijiazhuang
Response evaluation criteria in solid tumors

Click the tags to see associated articles and topics

View Article Details